loading
前日終値:
$4.45
開ける:
$4.5
24時間の取引高:
9,746
Relative Volume:
0.00
時価総額:
$417.10M
収益:
$823.60M
当期純損益:
$-116.00M
株価収益率:
-3.5154
EPS:
-1.3
ネットキャッシュフロー:
$-107.30M
1週間 パフォーマンス:
-8.60%
1か月 パフォーマンス:
-7.11%
6か月 パフォーマンス:
-62.79%
1年 パフォーマンス:
-83.53%
1日の値動き範囲:
Value
$4.47
$4.525
1週間の範囲:
Value
$4.425
$5.195
52週間の値動き範囲:
Value
$3.8119
$29.30

Myriad Genetics Inc Stock (MYGN) Company Profile

Name
名前
Myriad Genetics Inc
Name
セクター
Healthcare (1161)
Name
電話
801-584-3600
Name
住所
322 NORTH 2200 WEST, SALT LAKE CITY, UT
Name
職員
2,700
Name
Twitter
@myriadgenetics
Name
次回の収益日
2025-02-24
Name
最新のSEC提出書
Name
MYGN's Discussions on Twitter

MYGN を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Diagnostics & Research icon
MYGN
Myriad Genetics Inc
4.525 481.17M 823.60M -116.00M -107.30M -1.30
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
418.88 160.56B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
190.75 141.52B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
527.48 42.74B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
114.90 34.11B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
179.41 27.70B 15.50B 1.33B 2.16B 7.34

Myriad Genetics Inc Stock (MYGN) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-05-21 ダウングレード Scotiabank Sector Outperform → Sector Perform
2025-05-08 ダウングレード Wolfe Research Outperform → Peer Perform
2025-05-07 ダウングレード Wells Fargo Overweight → Equal Weight
2025-04-09 ダウングレード Guggenheim Buy → Neutral
2025-03-12 アップグレード Piper Sandler Neutral → Overweight
2025-02-12 開始されました Craig Hallum Buy
2024-12-10 開始されました UBS Neutral
2024-12-09 ダウングレード Leerink Partners Outperform → Market Perform
2024-09-19 開始されました Morgan Stanley Equal-Weight
2024-08-28 開始されました Wells Fargo Overweight
2024-06-27 開始されました Scotiabank Sector Outperform
2024-06-03 再開されました Jefferies Underperform
2024-05-08 アップグレード Leerink Partners Market Perform → Outperform
2023-12-21 再開されました Piper Sandler Neutral
2023-12-19 開始されました Wells Fargo Equal Weight
2023-12-14 開始されました Guggenheim Buy
2023-12-13 開始されました Wolfe Research Outperform
2023-07-05 再開されました JP Morgan Underweight
2023-05-23 アップグレード Goldman Sell → Buy
2023-01-18 アップグレード Raymond James Mkt Perform → Outperform
2022-10-06 開始されました Stephens Equal-Weight
2021-10-15 再開されました Cowen Market Perform
2021-06-15 開始されました Raymond James Mkt Perform
2021-06-03 開始されました Goldman Sell
2019-09-26 ダウングレード BofA/Merrill Neutral → Underperform
2019-08-14 ダウングレード Piper Jaffray Overweight → Neutral
2019-08-02 アップグレード BofA/Merrill Underperform → Neutral
2019-08-01 アップグレード Barclays Underweight → Equal Weight
2019-07-29 ダウングレード Needham Strong Buy → Hold
2019-07-09 ダウングレード Cowen Outperform → Market Perform
2019-03-12 繰り返されました Needham Strong Buy
2019-01-03 開始されました Needham Strong Buy
2018-11-30 アップグレード Goldman Sell → Neutral
2018-10-10 アップグレード Piper Jaffray Neutral → Overweight
2018-07-11 アップグレード Morgan Stanley Equal-Weight → Overweight
2018-03-21 アップグレード Morgan Stanley Underweight → Equal-Weight
2018-01-29 開始されました Goldman Sell
2018-01-22 繰り返されました Barclays Equal Weight
2018-01-05 開始されました BTIG Research Buy
2017-10-02 再開されました Leerink Partners Mkt Perform
2017-08-09 繰り返されました Barclays Equal Weight
2017-02-08 アップグレード Ladenburg Thalmann Sell → Neutral
2017-01-18 開始されました Deutsche Bank Sell
2016-10-10 ダウングレード Ladenburg Thalmann Neutral → Sell
すべてを表示

Myriad Genetics Inc (MYGN) 最新ニュース

pulisher
07:58 AM

What drives Myriad Genetics Inc. stock priceExceptional portfolio growth - jammulinksnews.com

07:58 AM
pulisher
Jul 21, 2025

Is Myriad Genetics Inc. a good long term investmentHigh-velocity gains - Autocar Professional

Jul 21, 2025
pulisher
Jul 21, 2025

What analysts say about Myriad Genetics Inc. stockTremendous growth potential - Autocar Professional

Jul 21, 2025
pulisher
Jul 21, 2025

Insider Sellers Might Regret Selling Myriad Genetics Shares at a Lower Price Than Current Market Value - simplywall.st

Jul 21, 2025
pulisher
Jul 21, 2025

Volatile Stocks to Avoid: Williams-Sonoma, Timken, and Myriad Genetics - AInvest

Jul 21, 2025
pulisher
Jul 19, 2025

Myriad Genetics Inc. Stock Analysis and ForecastRapid portfolio appreciation - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 18, 2025

Evolent Health, West Pharmaceutical Services, Myriad Genetics, Tandem Diabetes, and Integra LifeSciences Shares Are Falling, What You Need To Know - Yahoo Finance

Jul 18, 2025
pulisher
Jul 17, 2025

Trading (MYGN) With Integrated Risk Controls - news.stocktradersdaily.com

Jul 17, 2025
pulisher
Jul 15, 2025

Myriad Genetics Earns 2025 Great Place To Work Certification™ - The Manila Times

Jul 15, 2025
pulisher
Jul 15, 2025

Myriad Genetics Outperforms Average US Company by 30% in Workplace Excellence - Stock Titan

Jul 15, 2025
pulisher
Jul 11, 2025

Acadia Healthcare, 10x Genomics, Amphastar Pharmaceuticals, Myriad Genetics, and QuidelOrtho Stocks Trade Down, What You Need To Know - MSN

Jul 11, 2025
pulisher
Jul 10, 2025

Myriad Genetics (MYGN) Drops 3.85% Despite Expansion Efforts - AInvest

Jul 10, 2025
pulisher
Jul 09, 2025

Parp Inhibitor Biomarkers Market Is Booming So Rapidly By 2032 | Myriad Genetics, Inc., F. Hoffmann-La Roche AG - openPR.com

Jul 09, 2025
pulisher
Jul 06, 2025

Where are the Opportunities in (MYGN) - news.stocktradersdaily.com

Jul 06, 2025
pulisher
Jun 27, 2025

5 Revealing Analyst Questions From Myriad Genetics’s Q1 Earnings Call - Yahoo Finance

Jun 27, 2025
pulisher
Jun 25, 2025

INVESTOR ALERT: Investigation of Myriad Genetics, Inc. (MYGN) Announced by Holzer & Holzer, LLC - GlobeNewswire

Jun 25, 2025
pulisher
Jun 17, 2025

Should You Hold Myriad Genetics Stock in Your Portfolio Right Now? - MSN

Jun 17, 2025
pulisher
Jun 11, 2025

Myriad Genetics at Goldman Sachs Conference: Strategic Growth Amid Challenges - Investing.com Canada

Jun 11, 2025
pulisher
Jun 11, 2025

Transcript : Myriad Genetics, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-11-2025 02 - MarketScreener

Jun 11, 2025
pulisher
Jun 09, 2025

Consumer Genomics Market Is Booming So Rapidly 2025-2032 | Color - openPR.com

Jun 09, 2025
pulisher
Jun 08, 2025

5-DAY DEADLINE ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Myriad Genetics (MYGN) Investors Who Suffered Significant Losses to Contact Its Attorneys, Application Deadline is Approaching - ACCESS Newswire

Jun 08, 2025
pulisher
Jun 06, 2025

3 Reasons to Avoid MYGN and 1 Stock to Buy Instead - Yahoo Finance

Jun 06, 2025
pulisher
Jun 05, 2025

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Myriad Genetics (MYGN) Investors Who Suffered Significant Losses to Contact Its Attorneys, Application Deadline is Approaching - ACCESS Newswire

Jun 05, 2025
pulisher
Jun 05, 2025

Myriad (MYGN) Up 23.9% Since Last Earnings Report: Can It Continue? - Yahoo Finance

Jun 05, 2025
pulisher
Jun 04, 2025

Myriad Genetics Announces Early Access to the FirstGene Multiple Prenatal Screen - GlobeNewswire

Jun 04, 2025
pulisher
Jun 03, 2025

7-DAY DEADLINE ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Myriad Genetics (MYGN) Investors Who Suffered Significant Losses to Contact Its Attorneys, Application Deadline is Approaching - ACCESS Newswire

Jun 03, 2025
pulisher
Jun 03, 2025

FINAL DEADLINE ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Myriad Genetics (MYGN) Investors Who Suffered Significant Losses to Contact Its Attorneys, Application Deadline Tomorrow - ACCESS Newswire

Jun 03, 2025
pulisher
Jun 03, 2025

Trend Tracker for (MYGN) - news.stocktradersdaily.com

Jun 03, 2025
pulisher
Jun 03, 2025

US Direct-To-Consumer Genetic Testing Market Report 2025, - GlobeNewswire

Jun 03, 2025
pulisher
Jun 03, 2025

US Direct-To-Consumer Genetic Testing Market Report 2025, Competitive Analysis of 23andMe, Gene by Gene, Ancestry, Genesis, EasyDNA, Veritas, Myriad Genetics, Taconic Biosciences, & Color Health - Yahoo Finance

Jun 03, 2025
pulisher
Jun 03, 2025

Myriad Genetics (MYGN) Launches FirstGene Multiple Prenatal Screen | MYGN Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Myriad Genetics Launches FirstGene™ Prenatal Screen for Comprehensive Genetic Risk Assessment in One Blood Draw - Nasdaq

Jun 03, 2025
pulisher
Jun 03, 2025

Breakthrough Prenatal Screen Combines 4 Tests in 1 Blood DrawNo Father Sample Needed - Stock Titan

Jun 03, 2025
pulisher
Jun 03, 2025

Hereditary Testing MarketGlobal Industry Trends, - GlobeNewswire

Jun 03, 2025

Myriad Genetics Inc (MYGN) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
diagnostics_research WAT
$288.00
price up icon 1.48%
diagnostics_research DGX
$171.65
price up icon 1.99%
$140.68
price up icon 0.78%
diagnostics_research LH
$244.98
price up icon 1.71%
diagnostics_research MTD
$1,173.76
price up icon 0.27%
diagnostics_research IQV
$176.56
price up icon 8.92%
大文字化:     |  ボリューム (24 時間):